NanoString and partners establish joint lab for spatial genomics in Singapore

NanoString, the Agency for Science, Technology and Research ‘s – or A*STAR – Genome Institute of Singapore – GIS -, and Next Level Genomics – NLG -, are establishing a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. The new lab, called the SpACE-Dx lab – Spatial Atlas of Clinical Evolution of Disease -, will harness spatial multiomic – gene and protein expression – technologies to drive research in complex diseases, with a primary focus on cancer. The SpACE-Dx lab will be situated within A*STAR’s GIS facility and be accessible to the local research community. It aims to foster collaboration and accelerate advancements in spatial genomics research. NLG will provide the laboratory expertise in spatial genomics utilising NanoString instruments to aid researchers in applying cutting-edge spatial technology to their ongoing research. NanoString’s platforms allow researchers to measure the multi-modal expression of genes and proteins in the natural context of tissue structure, including diseased cells such as cancer cells and the cells within their microenvironment.